David Curtis, MBBS, PhD, FRACP, FRCPA, discusses the use of post-transplant cyclophosphamide GVHD prophylaxis in matched donor peripheral blood SCT.
David Curtis, MBBS, PhD, FRACP, FRCPA
Advertisement
David Curtis, MBBS, PhD, FRACP, FRCPA, is an associate professor and head of the Division of Blood Cancer Research of the Australian Centre for Blood Diseases at Monash University, Alfred Hospital
Articles by David Curtis, MBBS, PhD, FRACP, FRCPA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5